Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Marston

Showing results (281-290 of 325) with videos related to

Pageof 33
Sort By:
Circulation|April 1, 2020
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous ThromboembolismNicholas A Marston, Yared Gurmu, Giorgio E M Melloni, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 7, 2016
Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcersRobert S Kirsner, Wolfgang Vanscheidt, David H Keast, et al.
European Heart Journal|March 26, 2021
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyNicholas A Marston, Larry Han, Iacopo Olivotto, et al.
JAMA Cardiology|December 28, 2022
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary PreventionNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
European Journal of Preventive Cardiology|October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic DiseaseAndre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
Nature Medicine|August 6, 2024
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trialsNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
Plos One|March 23, 2013
A step forward in molecular diagnostics of lyssaviruses--results of a ring trial among European laboratoriesMelina Fischer, Kerstin Wernike, Conrad M Freuling, et al.
European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
Emergency Medicine Journal : EMJ|June 25, 2015
Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trialNicholas A Marston, Kevin S Shah, Christian Mueller, et al.
Pageof 33

Showing results (281-290 of 325) with videos related to

Sort By:
Pageof 33
Circulation|April 1, 2020
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous ThromboembolismNicholas A Marston, Yared Gurmu, Giorgio E M Melloni, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 7, 2016
Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcersRobert S Kirsner, Wolfgang Vanscheidt, David H Keast, et al.
European Heart Journal|March 26, 2021
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyNicholas A Marston, Larry Han, Iacopo Olivotto, et al.
JAMA Cardiology|December 28, 2022
Predictive Utility of a Coronary Artery Disease Polygenic Risk Score in Primary PreventionNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
The New England Journal of Medicine|September 1, 2025
Targeting <i>APOC3</i> with Olezarsen in Moderate HypertriglyceridemiaBrian A Bergmark, Nicholas A Marston, Thomas A Prohaska, et al.
European Journal of Preventive Cardiology|October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic DiseaseAndre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
Nature Medicine|August 6, 2024
Clonal hematopoiesis, cardiovascular events and treatment benefit in 63,700 individuals from five TIMI randomized trialsNicholas A Marston, James P Pirruccello, Giorgio E M Melloni, et al.
Plos One|March 23, 2013
A step forward in molecular diagnostics of lyssaviruses--results of a ring trial among European laboratoriesMelina Fischer, Kerstin Wernike, Conrad M Freuling, et al.
European Heart Journal|November 28, 2025
A polygenic risk score for peripheral artery disease and major adverse limb eventsSamer Al Said, Siddharth M Patel, Giorgio E M Melloni, et al.
Emergency Medicine Journal : EMJ|June 25, 2015
Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trialNicholas A Marston, Kevin S Shah, Christian Mueller, et al.
Pageof 33